TUZISTRA XR (Vernalis Therapeutics, Inc.)
Welcome to the PulseAid listing for the TUZISTRA XR drug offered from Vernalis Therapeutics, Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Vernalis Therapeutics, Inc. |
NON-PROPRIETARY NAME: | codeine polistirex and chlorpheniramine polistirex |
SUBSTANCE NAME: | CODEINE PHOSPHATE ANHYDROUS; CHLORPHENIRAMINE MALEATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-05-31 |
END MARKETING DATE: | 0000-00-00 |
TUZISTRA XR HUMAN PRESCRIPTION DRUG Details:
Item Description | TUZISTRA XR from Vernalis Therapeutics, Inc. |
LABELER NAME: | Vernalis Therapeutics, Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 14.7; 2.8(mg/5mL; mg/5mL) |
START MARKETING DATE: | 2015-05-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69442-480_49121b33-5e2e-403f-93e6-2d27c2d1c4f6 |
PRODUCT NDC: | 69442-480 |
APPLICATION NUMBER: | NDA207768 |
Other CODEINE PHOSPHATE ANHYDROUS; CHLORPHENIRAMINE MALEATE Pharmaceutical Manufacturers / Labelers: